USMLE® Step 2 CK · Endocrinology · Topic ENDO-ONC-02
Endocrinopathies of cancer immunotherapy (checkpoint inhibitors)
Endocrinopathies of cancer immunotherapy (checkpoint inhibitors) (ENDO-ONC-02) in USMLE® Step 2 CK Endocrinology (USMLE® Step 2 CK Review Book p. 456). Guideline basis: Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update (2021). Covers: Recognition — checkpoint inhibitor endocrinopathies, Management principles. Practice linked QuestionBank questions, ChartWalk bedside clinical algorithms, FlashCards, and ImageBank on TheCodexes.com. Understand beyond your boards.
- Topic Code
- ENDO-ONC-02
- Chapter
- Endocrinology
- Review Book Page
- p. 456
- QuestionBank Items
- 0 questions
Primary Guideline / Source: Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update (2021)
Key Clinical Sections
- Recognition — checkpoint inhibitor endocrinopathies
- Management principles